ATDC (Ataxia Telangiectasia Group D Complementing) Promotes Radioresistance through an Interaction with the RNF8...

Area of Science:

• Molecular Biology
• Cancer Research
• DNA Damage Response

Background:

• Ionizing radiation (IR) and chemotherapy induce DNA damage, a key cancer therapy mechanism.
• The ataxia telangiectasia group D complementing gene (ATDC) is upregulated in malignancies and aids cell survival post-IR.
• ATDC functions downstream of ATM and p38/MK2 in the DNA damage response.

Purpose of the Study:

• To identify ATDC binding partners and elucidate mechanisms of ATDC-induced radioresistance.
• To investigate the functional significance of the ATDC-RNF8 interaction in DNA repair.

Main Methods:

• Mass spectrometry was used to identify ATDC binding partners.
• Protein interaction mapping identified specific domains involved in ATDC-RNF8 binding.
• Mutational analysis was performed to assess the impact on radioresistance and DNA damage response.

Main Results:

• A direct physical interaction between ATDC and the E3 ubiquitin ligase RNF8 was identified.
• This interaction, localized to the ATDC C-terminus and RNF8 RING domain, is essential for ATDC-mediated radioresistance.
• IR increased the RNF8-ATDC interaction, enhancing downstream DNA repair events like γ-H2AX ubiquitination and 53BP1 phosphorylation.

Conclusions:

• ATDC plays a novel role in the RNF8-mediated DNA damage response.
• RNF8 binding is a critical determinant of ATDC's radioprotective function.
• Targeting the ATDC-RNF8 interaction could be a strategy in cancer therapy.